MTT #71: Why is this drug 19-times more expensive than it was in 2007?

On today’s episode of “Medicine: The Truth” (formerly “Coronavirus: The Truth”), hosts Dr. Robert Pearl and Jeremy Corr tackle more of healthcare’s hottest issues and biggest problems.

In this show, the hosts discuss the promise (and pitfalls) of generative AI and its future applications in medicine. Are patients ready to get their diagnoses and treatment plans from something (like ChatGPT) rather than someone (their doctor)?

The conversation then shifts to the monopolistic controls of drug makers and price-driving approaches that a longtime healthcare CEO and commentator Dr. Pearl says, “even I could never imagine.” Pearl describes a drug that generates $13 billion in revenue for a company that charges $200,000 per patient per year, 19-times more than it cost in 2007.

As always, Dr. Pearl and Jeremy eagerly follow the facts, uncover the truth, and help listeners understand how the world’s biggest healthcare stories affect us all. Click here for more info: https://www.fixinghealthcarepodcast.com/

* * *

Dr. Robert Pearl is the author of a book about medicine’s invisible yet highly influential physician culture. Check out “Uncaring: How Physician Culture Is Killing Doctors & Patients.” All profits from the book go to Doctors Without Borders.

Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn.

The post MTT #71: Why is this drug 19-times more expensive than it was in 2007? appeared first on Fixing Healthcare.